Two murine studies suggested triple combination of external beam irradiation, PD-1 blockade, and CD137 agonism to synergize in cancer treatment [205,206], suggesting mechanistic target of rapamycin (mTOR) signaling to be involved in the therapeutic mechanism. The gene discussed is MTOR; the disease is cancer.